Literature DB >> 20960195

[Multiple endocrine neoplasia type I].

E Koncz1, K W Schmid.   

Abstract

Multiple endocrine neoplasia type I (MEN1) is a rare hereditary cancer syndrome, which is manifested as a variety of endocrine and non-endocrine tumours and lesions caused by specific germline mutations of the MEN1 gene, a tumour suppressor gene. The detection of these germline mutations allows the early identification of affected, possibly still asymptomatic patients. The combined use of genetic and clinical tools for the diagnosis of MEN1-associated tumours substantially improves both the course of the disease and the quality of life of affected patients. This review summarizes the relevant morphological and clinical features of MEN1-associated endocrine and non-endocrine neoplasms and lesions.

Entities:  

Mesh:

Year:  2010        PMID: 20960195     DOI: 10.1007/s00292-010-1356-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  9 in total

1.  Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.

Authors:  Frederic Triponez; David Dosseh; Pierre Goudet; Patrick Cougard; Catherine Bauters; Arnaud Murat; Guillaume Cadiot; Patricia Niccoli-Sire; Jean-Alain Chayvialle; Alain Calender; Charles A G Proye
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 2.  Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.

Authors:  S J Marx; S K Agarwal; M B Kester; C Heppner; Y S Kim; M C Skarulis; L A James; P K Goldsmith; S K Saggar; S Y Park; A M Spiegel; A L Burns; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; M R Emmert-Buck; S C Guru; P Manickam; J Crabtree; M R Erdos; F S Collins; S C Chandrasekharappa
Journal:  Recent Prog Horm Res       Date:  1999

Review 3.  Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.

Authors:  K Martin Hoffmann; Masayuki Furukawa; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

4.  Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Laurence Thomas-Marques; Arnaud Murat; Brigitte Delemer; Alfred Penfornis; Catherine Cardot-Bauters; Eric Baudin; Patricia Niccoli-Sire; Damien Levoir; Hélène du Boullay Choplin; Olivier Chabre; Nicolas Jovenin; Guillaume Cadiot
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

5.  Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.

Authors:  M Anlauf; A Perren; T Henopp; T Rudolf; N Garbrecht; A Schmitt; A Raffel; O Gimm; E Weihe; W T Knoefel; H Dralle; Ph U Heitz; P Komminoth; G Klöppel
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

Review 6.  Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance.

Authors:  Martin Anlauf; Aurel Perren; Günter Klöppel
Journal:  Pathobiology       Date:  2007       Impact factor: 4.342

7.  Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity.

Authors:  A Agha; R Carpenter; S Bhattacharya; S J Edmonson; E Carlsen; J P Monson
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

Review 8.  Multiple endocrine neoplasia type 1 associated with spinal ependymoma.

Authors:  H Kato; I Uchimura; M Morohoshi; K Fujisawa; Y Kobayashi; F Numano; N Goseki; M Endo; A Tamura; C Nagashima
Journal:  Intern Med       Date:  1996-04       Impact factor: 1.271

Review 9.  Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.

Authors:  Alberto Falchetti; Francesca Marini; Ettore Luzi; Francesca Giusti; Loredana Cavalli; Tiziana Cavalli; Maria Luisa Brandi
Journal:  Genet Med       Date:  2009-12       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.